CBS 2019
CBSMD教育中心
中 文

经导管主动脉瓣置换

Abstract

Recommended Article

Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Replacement: JACC Review Topic of the Week Risk of Coronary Obstruction and Feasibility of Coronary Access After Repeat Transcatheter Aortic Valve Replacement With the Self-Expanding Evolut Valve: A Computed Tomography Simulation Study Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR Transcatheter Aortic Valve Replacement in Patients With Multivalvular Heart Disease Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey

JOURNAL: Article Link

CBS2025丨第十七届左主干暨冠状动脉分叉病变会议病例征集通知

qiaomingyue Keywords: 第十七届左主干暨冠状动脉分叉病变会议(CBS2025)将于2025年11月28日至30日在南京国际青年会议酒店举行。为促进临床工作经验的深入交流与广泛分享,本次会议特别设立了临床心血管介入治疗病例的专题交流专场。征集到的有效病例将由CBS组委会邀请的国内外心血管病专家组成的评审委员会进行统一评审。获录用的病例报告者将免除本届会议的注册费及食宿费,并将受邀在病例专场进行发言。

网站资料更新中...